Novartis plans to build flu-vaccine plant in U.S.
By Jeanne Whalen
The Wall Street Journal Europe
19 Jul 2006
Swiss drug maker Novartis AG said it plans to build a $600 million flu-vaccine plant in the U.S. that will use new technology designed to eliminate production glitches that can occur at older plants and result in flu-shot shortages. The factory... read more...
posted by Bank Report at
5:08 AM
0 Comments:
Post a Comment
<< Home